Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 4
1964 12
1968 2
1971 1
1972 1
1973 2
1974 2
1975 1
1977 1
1978 1
1979 4
1980 2
1981 3
1982 2
1983 6
1984 6
1985 7
1986 6
1987 6
1988 8
1989 7
1990 5
1991 11
1992 14
1993 13
1994 13
1995 21
1996 19
1997 21
1998 13
1999 18
2000 14
2001 26
2002 15
2003 35
2004 27
2005 38
2006 43
2007 57
2008 35
2009 39
2010 48
2011 53
2012 65
2013 62
2014 82
2015 76
2016 99
2017 101
2018 106
2019 105
2020 124
2021 116
2022 116
2023 95
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,581 results

Results by year

Filters applied: . Clear all
Page 1
MR Perfusion Imaging of the Lung.
Kay FU, Madhuranthakam AJ. Kay FU, et al. Magn Reson Imaging Clin N Am. 2024 Feb;32(1):111-123. doi: 10.1016/j.mric.2023.09.006. Epub 2023 Oct 19. Magn Reson Imaging Clin N Am. 2024. PMID: 38007274 Review.
MRI perfusion provides a radiation-free technique, making it an ideal choice for longitudinal imaging in younger populations. ...In conditions such as cystic fibrosis and lung cancer, MRI has displayed encouraging results, whereas in dise
MRI perfusion provides a radiation-free technique, making it an ideal choice for longitudinal imaging in younger populations.
Delayed identification of compound heterozygous (Phe508del/Arg117His) cystic fibrosis variants in a patient awaiting liver transplantation.
Hu M, McLellan T, Grogono D, Karia S, Herre J. Hu M, et al. BMJ Case Rep. 2023 Nov 21;16(11):e255602. doi: 10.1136/bcr-2023-255602. BMJ Case Rep. 2023. PMID: 37989334
Broncho-alveolar lavage was positive for Pseudomonas aeruginosa Genetic screening found two cystic fibrosis transmembrane conductance regulator variants: Phe508del and Arg117His-7T. The patient was referred to the regional cystic fibrosis (CF) centre f …
Broncho-alveolar lavage was positive for Pseudomonas aeruginosa Genetic screening found two cystic fibrosis transmembrane cond …
Anaerobic fluorescent reporters for live imaging of Pseudomonas aeruginosa.
Tchagang CF, Mah TF, Campbell-Valois FX. Tchagang CF, et al. Front Microbiol. 2023 Oct 20;14:1245755. doi: 10.3389/fmicb.2023.1245755. eCollection 2023. Front Microbiol. 2023. PMID: 37928662 Free PMC article.
Pseudomonas aeruginosa thrives in the airways of individuals with cystic fibrosis, in part by forming robust biofilms that are resistant to immune clearance or antibiotic treatment. In the cystic fibrosis lung, the thickened mucus layers create …
Pseudomonas aeruginosa thrives in the airways of individuals with cystic fibrosis, in part by forming robust biofilms that are …
Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis.
Sandvik RM, Schmidt MN, Voldby CM, Buchvald FF, Olesen HV, Olsen J, Kragh MV, Rubak SLM, Pressler T, Robinson PD, Gustafsson PM, Skov M, Nielsen KG. Sandvik RM, et al. ERJ Open Res. 2023 Oct 30;9(5):00317-2023. doi: 10.1183/23120541.00317-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37908398 Free PMC article.
BACKGROUND: Cystic fibrosis (CF) lung disease starts in infancy and can be assessed for structural lung abnormalities using computed tomography or magnetic resonance scans, or for lung function impairment using multiple breath wash …
BACKGROUND: Cystic fibrosis (CF) lung disease starts in infancy and can be assessed for structural lung abnormal …
Longitudinal Evaluation of Bronchial Changes in Cystic Fibrosis Patients Undergoing Elexacaftor/Tezacaftor/Ivacaftor Therapy Using Lung MRI With Ultrashort Echo-Times.
David M, Benlala I, Bui S, Benkert T, Berger P, Laurent F, Macey J, Dournes G. David M, et al. J Magn Reson Imaging. 2023 Oct 20. doi: 10.1002/jmri.29041. Online ahead of print. J Magn Reson Imaging. 2023. PMID: 37861357
BACKGROUND: Lung magnetic resonance imaging (MRI) with ultrashort echo-times (UTE-MRI) allows high-resolution and radiation-free imaging of the lung structure in cystic fibrosis (CF). ...POPULATION: Fifty CF pa …
BACKGROUND: Lung magnetic resonance imaging (MRI) with ultrashort echo-times (UTE-MRI) allows high …
PixelPrint: A collection of three-dimensional printed CT phantoms of different respiratory diseases.
Mei K, Roshkovan L, Pasyar P, Shapira N, Gang GJ, Stayman JW, Geagan M, Noël PB. Mei K, et al. Proc SPIE Int Soc Opt Eng. 2023 Feb;12463:124633Q. doi: 10.1117/12.2654343. Epub 2023 Apr 7. Proc SPIE Int Soc Opt Eng. 2023. PMID: 37854299 Free PMC article.
We recently developed a method (PixelPrint) for 3D-printing lifelike computed tomography (CT) lung phantoms, paving the way for future diagnostic imaging standardization. PixelPrint generates phantoms with accurate attenuation profiles and textures by directl …
We recently developed a method (PixelPrint) for 3D-printing lifelike computed tomography (CT) lung phantoms, paving the way fo …
[Magnetic resonance imaging of the lung : State of the art].
Wucherpfennig L, Kauczor HU, Eichinger M, Wielpütz MO. Wucherpfennig L, et al. Radiologie (Heidelb). 2023 Nov;63(11):849-862. doi: 10.1007/s00117-023-01229-1. Epub 2023 Oct 18. Radiologie (Heidelb). 2023. PMID: 37851088 German.
Due to the low proton density of the lung parenchyma and the rapid signal decay at the air-tissue interfaces, for a long time the lungs were difficult to access using magnetic resonance imaging (MRI); however, technical advances could address mo …
Due to the low proton density of the lung parenchyma and the rapid signal decay at the air-tissue interfaces, for a long time the lun …
The SPEC score-A quantifiable CT scoring system for primary ciliary dyskinesia.
Chowdhary T, Bracken J, Morgan L, Schultz A, Robinson P. Chowdhary T, et al. Pediatr Pulmonol. 2023 Oct 16. doi: 10.1002/ppul.26709. Online ahead of print. Pediatr Pulmonol. 2023. PMID: 37842974
BACKGROUND: Structural lung changes seen on computed tomography (CT) scans in persons with primary ciliary dyskinesia (pwPCD) are currently described using cystic fibrosis (CF) derived scoring systems. ...CONCLUSIONS: Using PCD-derived data we describe …
BACKGROUND: Structural lung changes seen on computed tomography (CT) scans in persons with primary ciliary dyskinesia (pwPCD) …
Airspace Diameter Map-A Quantitative Measurement of All Pulmonary Airspaces to Characterize Structural Lung Diseases.
Blaskovic S, Anagnostopoulou P, Borisova E, Schittny D, Donati Y, Haberthür D, Zhou-Suckow Z, Mall MA, Schlepütz CM, Stampanoni M, Barazzone-Argiroffo C, Schittny JC. Blaskovic S, et al. Cells. 2023 Sep 28;12(19):2375. doi: 10.3390/cells12192375. Cells. 2023. PMID: 37830589 Free PMC article.
It includes (i) high-resolution synchrotron radiation-based X-ray tomographic microscopy, (ii) image segmentation using the free machine-learning tool Ilastik and ImageJ, and (iii) calculation of the airspace diameter distribution using a diameter map function. To evaluate the ne …
It includes (i) high-resolution synchrotron radiation-based X-ray tomographic microscopy, (ii) image segmentation using the free machine-lea …
Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study.
Dettmer S, Weinheimer O, Sauer-Heilborn A, Lammers O, Wielpütz MO, Fuge J, Welte T, Wacker F, Ringshausen FC. Dettmer S, et al. Front Pharmacol. 2023 Sep 21;14:1245885. doi: 10.3389/fphar.2023.1245885. eCollection 2023. Front Pharmacol. 2023. PMID: 37808186 Free PMC article.
Introduction: The availability of highly effective triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator combination therapy with elexacaftor-tezacaftor-ivacaftor (ETI) has improved pulmonary outcomes and quality of life of people with …
Introduction: The availability of highly effective triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator …
1,581 results